Daily Living Performance in Schizophrenic Patients in Correlation with Positive and Negative Symptoms
Abstract
Background: Schizophrenia is a global mental health problem. Patients experience problems in their daily-living performance. Positive and negative symptoms have been part of characteristics of schizophrenia that are absent in normal individuals, which include a distinctive fundamental distortion of thoughts and perception (positive symptoms) and loss of normal function and behavior (negative symptoms). This study aimed to explore the correlation between positive and negative symptoms and daily-living performance in schizophrenia.
Methods: A correlative analytical study with a cross-sectional approach was conducted using secondary data from the Outpatient Clinic of the Mental Hospital of West Java Province. Data on socio-demographic characteristics were collected and positive and negative symptoms as assessed by Positive and Negative Syndrome Scale or Subscales (PANSS) were correlated with the activities of daily living (ADLs) and instrumental activities of daily living (IADLs), which were further analyzed by Spearman’s correlation test.
Results: In total, 31 male schizophrenic patients aged between 24-45 years old. There was no significant correlation between ADLs dependency levels and both positive and negative symptoms. However, there was a significant correlation between IADLs function and positive symptoms and not with negative symptoms.
Conclusions: Even though no correlation was identified between ADLs dependency levels with positive and negative symptoms, the ADLs and IADLs assessments should be considered as important tools for schizophrenic patients for rehabilitation to improve daily-living functioning.
Keywords
Full Text:
PDFReferences
Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, et al. Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease study 2016. Schizophr Bull. 2018;44(6):1195–203.
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar (Riskesdas) 2013. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI; 2013.
Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.
Maisyarah TA, Nugraha GI, Lidyana L. Nutritional status of schizophrenic patients at Department of Psychiatry in Dr. Hasan Sadikin General Hospital. Althea Medical Journal. 2014;1(1):40–7.
Viertiö S, Tuulio-Henriksson A, Perälä J, Saarni SI, Koskinen S, Sihvonen M, et al. Activities of daily living, social functioning and their determinants in persons with psychotic disorder. Eur Psychiatry. 2012;27(6):409–15.
Carter JW, Parnas J, Urfer-Parnas A, Watson J, Mednick SA. Intellectual functioning and the long-term course of schizophrenia-spectrum illness. Psychol Med. 2011;41(6):1223–37.
Mlinac ME, Feng MC. Assessment of Activities of Daily Living, Self-Care, and Independence. Arch Clin Neuropsychol. 2016;31(6):506–16.
Lipskaya L, Jarus T, Kotler M. Influence of cognition and symptoms of schizophrenia on IADL performance. Scand J Occup Ther. 2011;18(3):180–7.
Samuel R, Thomas E, Jacob KS. Instrumental Activities of Daily Living Dysfunction among People with Schizophrenia. Indian J Psychol Med. 2018;40(2):134–8.
Wijesundara H, Dayabandara M, Ellepola A, Hanwella R. Psychopathology in patients with schizophrenia attending a psychiatry outpatient clinic at a tertiary care hospital. Sri Lanka J Psychiatry. 2011;2(1).
Leucht S, Barabássy Á, Laszlovszky I, Szatmári B, Acsai K, Szalai E, et al. Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia. Neuropsychopharmacology. 2019;44(9):1589–96.
Dolai MC, Chakrabarty F. Functional status of the elderly santal people. Indian J Gerontol. 2013;27(4):610–20.
Ayres H, Ngo H, John AP. Limited changes in activities of daily life performance ability among people with schizophrenia at clinical settings and the factors moderating the changes. Schizophr Res Cogn. 2019;16:29–35.
Reichenberg A, Feo C, Prestia D, Bowie CR, Patterson TL, Harvey PD. The course and correlates of everyday functioning in schizophrenia. Schizophr Res Cogn. 2014;1(1):e47–52.
Harvey PD, Strassnig M. Predicting the severity of everyday functional disability in people with schizophrenia: Cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry. 2012;11(2):73–9.
Strassnig M, Signorile J, Gonzalez C, Harvey PD. Physical performance and disability in schizophrenia. Schizophr Res Cogn. 2014;1(2):112–21.
Aubin G, Chapparo C, Rainville C, Gélinas I, Stip E. Daily activities, cognition and community functioning in persons with schizophrenia. Schizophr Res. 2009;107(2–3):313–8.
Leifker FR, Bowie CR, Harvey PD. Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr Res. 2009;115(1):82–7.
Bechi M, Bosia M, Spangaro M, Buonocore M, Cavedoni S, Agostoni G, et al. Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour. Psychiatry Res. 2017;251:118–24.
DOI: https://doi.org/10.15850/amj.v7n2.1870
Article Metrics
Abstract view : 1171 timesPDF - 530 times
This Journal indexed by
AMJ is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
View My Stats